Substrate probe for the mechanism of aromatic hydroxylation catalyzed by cytochrome P450

Drug Metabolism and Disposition

Volumn 24, Issue 9, 1996, Pages 1038-1045

  Darbyshire, John F ^a   Iyer, Krishna R ^a,c   Grogan, Jim ^b,d   Korzekwa, Kenneth R ^b,e   Trager, William F ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c PFIZER INC   (United States)

^d ROSS UNIVERSITY SCHOOL OF MEDICINE   (Dominica)

^e UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; COMPLEMENTARY DNA; CYTOCHROME P450; CYTOCHROME P450 ISOENZYME; DEUTERIUM; DRUG METABOLITE; WARFARIN;

ANIMAL CELL; ARTICLE; CELL LINE; DERIVATIZATION; DRUG HYDROXYLATION; DRUG METABOLISM; DRUG STRUCTURE; ENANTIOMER; GAS CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEREOCHEMISTRY;

ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 ENZYME SYSTEM; DEUTERIUM; HYDROXYLATION; STEREOISOMERISM; STEROID 16-ALPHA-HYDROXYLASE; STEROID HYDROXYLASES; WARFARIN;

ANIMALIA;

EID: 0029790048     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. D. M. Jerina and J. W. Daly: Arene oxides: a new aspect of drug metabolism. Science 185, 573-582 (1974).
2. J. W. Daly, D. M. Jerina, and B. Witkop: Arene oxides and the NIH shift: the metabolism, toxicity and carcinogenicity of aromatic compounds. Experientia 28, 1129-1150 (1972).
3. S. D. Nelson, M. R. Boyd, and J. R. Mitchell: Role of metabolic activation in chemical-induced tissue injury. In "Drug Metabolism Concepts" (D. M. Jerina, ed.), pp. 155-185. ACS Symposium Series No. 44, American Chemical Society, Washington, D.C., 1977.
4. J. B. Tomaszewski, D. M. Jerina, and J. W. Daly: Deuterium isotope effects during formation of phenols by hepatic monooxygenases. Evidence for an alternative to the arene oxide pathway. Biochemistry 14, 2024-2031 (1975).
5. L. T. Burka, T. M. Plucinski, and T. L. MacDonald: Mechanisms of hydroxylation by cytochrome P-450: metabolism of monohalobenzenes by phenobarbital-induced microsomes. Proc. Natl. Acad. Sci. U.S.A. 80, 6680-6684 (1983).
6. G. Guroff, J. W. Daly, D. M. Jerina, J. Renson, B. Witkop, and S. Udenfriend: Hydroxylation-induced migration: the NIH shift. Science 158, 1524-1530 (1967).
7. 14C]chlorobenzene by hepatic microsomes. J. Am. Chem. Soc. 97, 4428-4430 (1975).
8. H. G. Selander, D. M. Jerina, and J. W. Daly: Metabolism of chlorobenzene with hepatic microsomes and solubilized cytochrome P-450 systems. Arch. Biochem. Biophys. 168, 309-321 (1975).
9. B. D. Preston, J. A. Miller, and E. C. Miller: Non-arene oxide aromatic ring hydroxylation of 2,2′,5,5′-tetrachlorobiphenyl as the major metabolic pathway catalyzed by phenobarbital-induced rat liver microsomes. J. Biol. Chem. 258, 8304-8311 (1983).
10. D. C. Swinney, W. N. Howald, and W. F. Trager: Intramolecular isotope effects associated with meta-hydroxylation of biphenyl catalyzed by cytochrome P-450. Biochem. Biophys. Res. Commun. 118, 867-872 (1984).
11. K. R. Korzekwa, D. C. Swinney, and W. F. Trager: Isotopically labeled chlorobenzenes as probes for the mechanism of cytochrome P-450 catalyzed aromatic hydroxylation. Biochemistry 28, 9019-9027 (1989).
12. E. D. Bush and W. F. Trager: Substrate probes for the mechanism of aromatic hydroxylation catalyzed by cytochrome P-450: selectively deuterated analogs of warfarin. J. Med. Chem. 28, 992-996 (1985).
13. R. P. Hanzlik, K. Hogberg, and C. M. Judson: Microsomal hydroxylation of specifically deuterated monosubstituted benzenes. Evidence for direct aromatic hydroxylation. Biochemistry 23, 3048-3055 (1984).
14. N. H. P. Cnubben, S. Peelan, J. W. Borst, J. Vervoort, C. Veeger, and I. M. C. M. Rietjens: Molecular orbital-based quantitative structure-activity relationship for the cytochrome P450-catalyzed 4-hydroxylation of halogenated anilines. Chem. Res. Toxicol. 7, 590-598 (1994).
15. P. F. Fitzpatrick: Kinetic isotope effects on hydroxylation of ring-deuterated phenylalanines by tyrosine hydroxylase provide evidence against partitioning of an arene oxide intermediate. J. Am. Chem. Soc. 116, 1133-1134 (1994).
16. I. M. C. M. Rietjens, A. E. M. F. Soffers, C. Veeger, and J. Vervoort: Regioselectivity of cytochrome P-450 catalyzed hydroxylation of fluorobenzenes predicated by calculated frontier orbital substrate characteristics. Biochemistry 32, 4801-4812 (1993).
17. T. Kurata, Y. Watanabe, M. Katoh, and Y. Sawaki: Mechanism of aromatic hydroxylation in the Fenton and related reactions. One-electron oxidation and the NIH shift. J. Am. Chem. Soc. 110, 7472-7478 (1988).
18. M. S. Nasir, B. I. Cohen, and K. D. Karlin: Mechanism of aromatic hydroxylation in a copper monooxygenase model system. 1,2-Methyl migrations and the NIH shift in copper chemistry. J. Am. Chem. Soc. 114, 2482-2494 (1992).
19. L. Castle, J. R. Lindsay-Smith, and G. V. Buxton: Aromatic hydroxylation by oxy-radicals - a possible model for hydroxylation catalyzed by cytochrome P450. J. Mol. Catal. 7, 235-243 (1980).
20. C. Walling and R. A. Johnson: Fenton's reagent. V. Hydroxylation and side-chain cleavage of aromatics. J. Am. Chem. Soc. 97, 363-367 (1975).
21. F. Minisci, A. Cittero, and C. Giordano: Electron-transfer processes: peroxydisulfate, a useful and versatile reagent in organic chemistry. Acc. Chem. Res. 16, 27-32 (1983).
22. C. Walling, D. M. Camioni, and S. S. Kim: Aromatic hydroxylation by peroxydisulfate. J. Am. Chem. Soc. 100, 4814-4818 (1978).
23. M. E. Snook and G. A. Hamilton: Oxidation and fragmentation of some phenyl-substituted alcohols and ethers by peroxydisulfate and Fenton's reagent. J. Am. Chem. Soc. 96, 860-869 (1974).
24. K. R. Korzekwa, W. F. Trager, M. Gouterman, D. Spangler, and G. Loew: Cytochrome P450 mediated aromatic oxidation: a theoretical study. J. Am. Chem. Soc. 107, 4273-4279 (1985).
25. A. E. Rettie, K. R. Korzekwa, K. L. Kunze, R. F. Lawrence, A. C. Eddy, T. Aoyama, H. V. Gelboin, F. J. Gonzalez, and W. F. Trager: Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions. Chem. Res. Toxicol. 5, 54-59 (1992).
26. L. S. Kaminsky, S. M. F. de Morais, M. B. Faletto, D. A. Dunbar, and J. A. Goldstein: Correlation of human cytochrome P4502C substrate specificities with primary structure: warfarin as a probe. Mol. Pharmacol. 43, 234-239 (1993).
27. M. A. Hermodson, W. M. Barker, and K. P. Link: Studies on the 4-hydroxycoumarins. Synthesis of the metabolites and some other derivatives of warfarin. J. Med. Chem. 14, 167-169 (1971).
28. K. A. Thakar: Application of the Fries and Friedel-Crafts reaction to m-halogenophenyl acetates and m-halogenophenols. J. Ind. Chem. Soc. 40, 539-542 (1963).
29. D. R. Buckle, B. C. C. Cantello, H. Smith, and B. A. Spicer: Antiallergic activity of 4-hydroxy-3-nitrocoumarins. J. Med. Chem. 18, 391-394 (1975).
30. R. A. Egli: Catalyzed dehalogenation by sodium borohydride. Helv. Chim. Acta. 51, 2090-2097 (1968).
31. T. R. Bosin, M. G. Raymond, and A. R. Buckpitt: A site-specific method for deuteration: reduction of aryl halides with sodium borodeuteride and palladium chloride. Tetrahedron Lett. 47, 4699-4700 (1973).
32. K. K. Chan, D. D. Giannini, A. H. Cain, J. D. Roberts, W. Porter, and W. F. Trager: Carbon-13 nuclear magnetic resonance studies of coumarin and related compounds. Tetrahedron 33, 899-906 (1977).
33. 3H. J. Labelled Compd. Radiopharm. 16, 623-631 (1978).
34. C. Banfield and M. Rowland: Stereospecific high-performance liquid chromatographic analysis of warfarin in plasma. J. Pharm. Sci. 72, 921-924 (1983).
35. J. Grogan, M. Shou, E. A. Andrusiak, S. Tamura, J. T. M. Buters, F. J. Gonzalez, and K. R. Korzekwa: Cytochrome P450 2A1, 2E1 and 2C9 cDNA-expression by insect cells and partial purification using hydrophobic chromatography. Biochem. Pharm. 50, 1509-1515 (1995).
36. R. Tenhunen, H. S. Marver, and R. Schmid: The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc. Natl. Acad. Sci. U.S.A. 61, 748-755 (1968).
37. F. J. Gonzalez, S. Kimura, S. Tamura, and H. V. Gelboin: Expression of mammalian cytochrome P450 using baculovirus. In "Methods in Enzymology" (M. R. Waxman and E. F. Johnson, eds.), vol. 206, pp. 93-99. Academic Press, New York, 1991.
38. F. J. Gonzalez, T. Aoyama, and H. V. Gelboin: Expression of mammalian cytochrome P450 using vaccinia virus. In "Methods in Enzymology" (M. R. Waxman and E. F. Johnson, eds.), vol. 206, pp. 85-92. Academic Press, New York, 1991.
39. T. Omura and R. Sato: The carbon monoxide pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem. 239, 2370-2378 (1964).
40. T. Omura and R. Sato: The carbon monoxide binding pigment of liver microsomes. II. Solubilization, purification, and properties. J. Biol. Chem. 239, 2379-2385 (1964).